Exhibit 31.1

                                 CERTIFICATIONS
                    required by Rules 13a-14(a) or 15d-14(a)

I, Lee Cole, certify that:

         1. I have reviewed this quarterly report on Form 10-QSB of
Bioaccelerate Holdings, Inc., the issuer;

         2. Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;

         3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the issuer as of,
and for, the periods presented in this report;

         4. The issuer's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
issuer and have:

         a. Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the issuer, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

         b. Designed such internal control over financial reporting, or caused
such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;

         c. Evaluated the effectiveness of the issuer's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and d. Disclosed in this report any
change in the issuer's internal control over financial reporting that occurred
during the issuer's most recent fiscal quarter (the issuer's fourth fiscal
quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the issuer's internal control over
financial reporting; and

         5. The issuer's other certifying officers and I have disclosed, based
on our most recent evaluation, to the issuer's auditors and the audit committee
of the issuer's board of directors (or persons performing the equivalent
functions):

         a. All significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are reasonably
likely to adversely affect the issuer's ability to record, process, summarize
and report financial information; and

         b. Any fraud, whether or not material, that involves management or
other employees who have a significant role in the issuer's internal control
over financial reporting.

Date: November 17, 2004                   By: /s/ Lee Cole
                                             ---------------------------------
                                                  Lee Cole, President & Director
                                                  (Chief Executive Officer)